Asarfi Hospital [ASARFI] vs Apollo Hospitals [APOLLOHOSP] Detailed Stock Comparison
Asarfi Hospital
BSE
Loading...
Apollo Hospitals
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Asarfi Hospital wins in 11 metrics, Apollo Hospitals wins in 6 metrics, with 0 ties. Asarfi Hospital appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Asarfi Hospital | Apollo Hospitals | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.44 | 72.09 | Asarfi Hospital |
| Price-to-Book Ratio | 3.06 | 12.70 | Asarfi Hospital |
| Debt-to-Equity Ratio | 55.65 | 90.89 | Asarfi Hospital |
| PEG Ratio | N/A | 88.87 | N/A |
| EV/EBITDA | 11.56 | 38.65 | Asarfi Hospital |
| Profit Margin (TTM) | 8.83% | 6.63% | Asarfi Hospital |
| Operating Margin (TTM) | 14.60% | 10.20% | Asarfi Hospital |
| EBITDA Margin (TTM) | 14.60% | 10.20% | Asarfi Hospital |
| Return on Equity | 14.56% | 18.85% | Apollo Hospitals |
| Return on Assets (TTM) | 5.28% | 7.60% | Apollo Hospitals |
| Free Cash Flow (TTM) | $-161.37M | $4.24B | Apollo Hospitals |
| Dividend Yield | N/A | 0.27% | N/A |
| 1-Year Return | 103.60% | 8.56% | Asarfi Hospital |
| Price-to-Sales Ratio (TTM) | 1.97 | 4.78 | Asarfi Hospital |
| Enterprise Value | $3.03B | $1,081.59B | Apollo Hospitals |
| EV/Revenue Ratio | 2.32 | 4.96 | Asarfi Hospital |
| Gross Profit Margin (TTM) | 77.89% | 47.63% | Asarfi Hospital |
| Revenue per Share (TTM) | $66 | $1,516 | Apollo Hospitals |
| Earnings per Share (Diluted) | $5.37 | $100.60 | Apollo Hospitals |
| Beta (Stock Volatility) | N/A | 0.16 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Asarfi Hospital vs Apollo Hospitals Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Asarfi Hospital | -1.15% | -1.52% | -11.56% | 33.62% | 44.20% | 30.04% |
| Apollo Hospitals | -0.31% | -0.67% | 0.97% | 4.81% | 14.91% | -1.50% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Asarfi Hospital | 103.60% | 15.56% | 15.56% | 15.56% | 15.56% | 15.56% |
| Apollo Hospitals | 8.56% | 75.54% | 332.73% | 457.38% | 1,684.72% | 3,824.21% |
Performance & Financial Health Analysis: Asarfi Hospital vs Apollo Hospitals
| Metric | ASARFI | APOLLOHOSP |
|---|---|---|
| Market Information | ||
| Market Cap | ₹2.58B | ₹1.04T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 10,500 | 315,369 |
| 90 Day Avg. Volume | 20,133 | 459,503 |
| Last Close | ₹128.50 | ₹7,236.50 |
| 52 Week Range | ₹52.84 - ₹150.00 | ₹6,001.00 - ₹7,635.00 |
| % from 52W High | -14.33% | -5.22% |
| All-Time High | ₹150.00 (Jul 11, 2025) | ₹552,030.00 (Nov 20, 2023) |
| % from All-Time High | -14.33% | -98.69% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.38% | 0.13% |
| Quarterly Earnings Growth | 0.45% | 0.54% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.07% |
| Operating Margin (TTM) | 0.15% | 0.10% |
| Return on Equity (TTM) | 0.15% | 0.19% |
| Debt to Equity (MRQ) | 55.65 | 90.89 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹42.85 | ₹571.15 |
| Cash per Share (MRQ) | ₹0.85 | ₹139.82 |
| Operating Cash Flow (TTM) | ₹26.36M | ₹21.36B |
| Levered Free Cash Flow (TTM) | ₹43.26M | ₹-6,159,499,776 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.27% |
| Last 12-Month Dividend | N/A | ₹19.00 |
Valuation & Enterprise Metrics Analysis: Asarfi Hospital vs Apollo Hospitals
| Metric | ASARFI | APOLLOHOSP |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.44 | 72.09 |
| Forward P/E | N/A | 88.87 |
| PEG Ratio | N/A | 88.87 |
| Price to Sales (TTM) | 1.97 | 4.78 |
| Price to Book (MRQ) | 3.06 | 12.70 |
| Market Capitalization | ||
| Market Capitalization | ₹2.58B | ₹1.04T |
| Enterprise Value | ₹3.03B | ₹1.08T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.32 | 4.96 |
| Enterprise to EBITDA | 11.56 | 38.65 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.16 |
| Book Value per Share (MRQ) | ₹42.85 | ₹571.15 |
Financial Statements Comparison: Asarfi Hospital vs Apollo Hospitals
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ASARFI | APOLLOHOSP |
|---|---|---|
| Revenue/Sales | ₹338.92M | ₹55.92B |
| Cost of Goods Sold | ₹74.95M | ₹29.29B |
| Gross Profit | ₹263.97M | ₹26.64B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹18.23M | ₹5.59B |
| EBITDA | ₹98.93M | ₹8.41B |
| Pre-Tax Income | ₹52.95M | ₹5.16B |
| Income Tax | ₹17.06M | ₹1.01B |
| Net Income (Profit) | ₹35.89M | ₹4.15B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ASARFI | APOLLOHOSP |
|---|---|---|
| Cash & Equivalents | ₹14.26M | ₹5.78B |
| Total Current Assets | ₹584.84M | ₹70.29B |
| Total Current Liabilities | ₹410.39M | ₹45.79B |
| Long-Term Debt | ₹338.29M | ₹68.31B |
| Total Shareholders Equity | ₹809.83M | ₹86.53B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹1.02B | ₹98.16B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ASARFI | APOLLOHOSP |
|---|---|---|
| Operating Cash Flow | ₹-93.10M | N/A |
| Capital Expenditures | ₹-38.61M | N/A |
| Free Cash Flow | ₹-106.81M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ASARFI | APOLLOHOSP |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 10,500 | 315,369 |
| Average Daily Volume (90 Day) | 20,133 | 459,503 |
| Shares Outstanding | 19.68M | 143.78M |
| Float Shares | 5.65M | 98.39M |
| % Held by Insiders | 0.70% | 0.30% |
| % Held by Institutions | 0.00% | 0.48% |
Dividend Analysis & Yield Comparison: Asarfi Hospital vs Apollo Hospitals
| Metric | ASARFI | APOLLOHOSP |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹19.00 |
| Last 12-Month Dividend Yield | N/A | 0.27% |
| 3-Year Avg Annual Dividend | N/A | ₹20.25 |
| 3-Year Avg Dividend Yield | N/A | 0.17% |
| 3-Year Total Dividends | N/A | ₹60.75 |
| Ex-Dividend Date | N/A | Feb 14, 2025 |